KRO: Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/Polymer
What it covers
A knee joint femorotibial metal/polymer constrained cemented prosthesis is a device intended to be implanted to replace part of a knee joint. The device limits translation or rotation in one or more planes and has components that are linked together or affined. This generic type of device includes prostheses composed of a ball-and-socket joint located between a stemmed femoral and a stemmed tibial component and a runner and track joint between each pair of femoral and tibial condyles. The ball-and-socket joint is composed of a ball at the head of a column rising from the stemmed tibial component. The ball, the column, the tibial plateau, and the stem for fixation of the tibial component are made of an alloy, such as cobalt-chromium-molybdenum. The ball of the tibial component is held within the socket of the femoral component by the femoral component's flat outer surface. The flat outer surface of the tibial component abuts both a reciprocal flat surface within the cavity of the femoral component and flanges on the femoral component designed to prevent distal displacement. The stem of the femoral component is made of an alloy, such as cobalt-chromium-molybdenum, but the socket of the component is made of ultra-high molecular weight polyethylene. The femoral component has metallic runners which align with the ultra-high molecular weight polyethylene tracks that press-fit into the metallic tibial component. The generic class also includes devices whose upper and lower components are linked with a solid bolt passing through a journal bearing of greater radius, permitting some rotation in the transverse plane, a minimal arc of abduction/adduction. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).
The identification in 21 CFR 888.3510, knee joint femorotibial metal/polymer constrained cemented prosthesis. FDA gives KRO no definition of its own, so the regulation’s describes it.
FDA flags KRO devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261898 | Triathlon® Knee System; Triathlon® Hinge Knee System; Scorpio® Total Knee System | Howmedica Osteonics Corp. dba Stryker Orthopaedics | Aug 6, 2026 | Traditional |
| K252898 | Triathlon® Tritanium® Asymmetric Patella; Triathlon® Tritanium® Symmetric Patella; Triathlon® Symmetric Patella; Triathlon® Asymmetric Patella; Scorpio® Universal Dome Patella; Triathlon® Hinge Bumper | Howmedica Osteonics Corp., Dba Stryker Orthopaedics | Dec 15, 2025 | Traditional |
| K252303 | Stem Extension Line (USTAR II System) | United Orthopedic Corporation | Aug 22, 2025 | Special |
| K251665 | Triathlon® Hinge Knee System | Howmedica Osteonics Corp., Dba Stryker Orthopaedics | Jul 25, 2025 | Traditional |
| K242871 | ATTUNE Revision Hinge Knee | Depuy Ireland UC | Nov 21, 2024 | Traditional |
| K240043 | EVOLUTION® Hinge Knee System;GUARDIAN limb Salvage System;DCW Modular Distal Femoral System;REPIPHYSIS Limb Salvage System;EVOLUTION® MP Total Knee System; EVOLUTION® MP Total Knee System; EVOLUTION® MP Adaptive CS Insert; EVOLUTION® MP Adaptive PS Tibial Insert; EVOLUTION® MP CS/CR Porous Femur/EVOLUTION® Adaptive CS and PS Inserts; EVOLUTION® Revision CCK System; ADVANCE® Double High Insert; ADVANCE® A-CLASS® Tibial Insert; ADVANCE® Knee System; ADVANCE® Ultra-Congruent Tibial Inse | Microport Orthopedics, Inc. | Apr 1, 2024 | Traditional |
| K233980 | ATTUNE Total Knee System, ATTUNE Cementless Knee System, LPS Limb Preservation System, Sigma High Performance (HP) Partial Knee System | Depuy Ireland UC | Mar 21, 2024 | Traditional |
| K230563 | EVOLUTION® Hinge Knee System | Microport Orthopedics, Inc. | Sep 27, 2023 | Traditional |
| K230416 | Triathlon® Hinge Knee System; Triathlon® Revision Insert X3® | Stryker | May 19, 2023 | Traditional |
| K223069 | Modular Rotating Hinge Knee Systems and Compatible Components | Howmedica Osteonics Corp., Dba Stryker Orthopaedics | Apr 21, 2023 | Traditional |
Clearances by year
38 KRO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 62 |
| 2025 | 3 | 56 |
| 2024 | 3 | 87 |
| 2023 | 4 | 148 |
| 2022 | 1 | 60 |
| 2021 | 3 | 57 |
| 2020 | 1 | 437 |
| 2019 | 3 | 244 |
| 2017 | 1 | 90 |
| 2016 | 3 | 148 |
| 2015 | 6 | 113 |
| 2014 | 2 | 75 |
| 2013 | 3 | 189 |
| 2012 | 2 | 162 |
| 2011 | 2 | 352 |
Who submits
20 applicants cleared a KRO device since 2011. 66% of the clearances went to applicants in United States, then Germany (13%), Switzerland (8%) and Ireland (8%). By type: Traditional 82% and Special 18%.
| Applicant | Clearances since 2011 |
|---|---|
| Stanmore Implants Worldwide , Ltd. | 5 |
| Waldemar Link GmbH & Co. KG | 5 |
| Howmedica Osteonics Corp., Dba Stryker Orthopaedics | 4 |
| Medacta International S.A. | 3 |
| Zimmer, Inc. | 3 |
| Depuy Ireland UC | 2 |
| Microport Orthopedics, Inc. | 2 |
| United Orthopedic Corporation | 2 |
How FDA classifies it
Class II.
From 21 CFR 888.3510.
Standards
21 CFR 888.3510 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KRO clearances declared.
Ask about KRO
Questions about KRO
What is FDA product code KRO?
Product code KRO, “Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/Polymer” in FDA's classification database, is a Class II device type under 21 CFR 888.3510 (knee joint femorotibial metal/polymer constrained cemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 87 clearances under KRO, 38 of them since 2011.
How many 510(k) clearances are there under KRO?
FDA’s 510(k) database listed 87 clearances under KRO as of Oct 29, 2026, 38 of them decided since 2011; the most recent decision was Aug 6, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a KRO 510(k)?
For the 5 KRO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 59 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most KRO clearances?
Since 2011: Stanmore Implants Worldwide , Ltd. (5), Waldemar Link GmbH & Co. KG (5), Howmedica Osteonics Corp., Dba Stryker Orthopaedics (4), Medacta International S.A. (3) and Zimmer, Inc. (3). 20 applicants have cleared a KRO device in that time.